AI Summary

Researchers from The Royal Marsden NHS Foundation Trust, the Institute of Cancer Research in London, and University College London have developed a blood test that may pinpoint men with advanced prostate cancer who are more likely to achieve longer disease control after targeted radiotherapy. The study suggests the test could guide treatment decisions by identifying patients who would benefit most from this approach. Results of the investigation were published in JAMA Network Open.

AI summaries can be wrong sometimes—always verify important details using the source article.